Surveillance of pediatric HIV infection

Pediatrics

Volumn 101, Issue 2, 1998, Pages 315-319

  Wilfert, C ^a   Beck, D T ^a   Fleischman, A R ^a   Mofenson, L M ^a   Pantell, R H ^a   Schonberg, S K ^a   Scott, G B ^a   Sklaire, M W ^a   Whitley Williams, P N ^a   Rogers, M F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONFIDENTIALITY; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION CONTROL; PATIENT COUNSELING; PRIORITY JOURNAL; REVIEW; VIRUS TRANSMISSION;

CHILD; CONFIDENTIALITY; HIV INFECTIONS; HIV SEROPREVALENCE; HUMANS; POPULATION SURVEILLANCE;

EID: 0031885132     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.101.2.315     Document Type: Review

References (32)

1. Centers for Disease Control. HIV infection reporting: United States. MMWR. 1989;38:496-499
2. Centers for Disease Control. Guidelines for evaluating surveillance systems. MMWR. 1988;37(suppl S-5):1-18
3. American Academy of Pediatrics, Provisional Committee on Pediatric AIDS. Perinatal human immunodeficiency virus testing. Pediatrics. 1995; 95:303-307
4. Hale R, Zinberg S. ACOG's position on HIV testing. ACOG Clin Rev. 1997;2:1, 13
5. DeGruttola V, Tu XM, Pagano M. Pediatric AIDS in New York City: estimating the distributions of infection, latency and reporting delay and projecting future incidence. J Am Stat Assoc. 1992;87:633-640
6. MaWhinney S, Pagano M, Thomas P. Age at AIDS diagnosis for children with perinatally acquired HIV. J Acquir Immune Defic Syndr. 1993; 6:1139-1144
7. Frederick T, Mascola L, Eller A, et al. Progression of human immunodeficiency virus disease among infants and children infected perinatally with human immunodeficiency virus or through neonatal blood transfusion. Pediatr Infect Dis J. 1994;13:1091-1097
8. The European Collaborative Study. Natural history of vertically acquired human immunodeficiency virus type 1 infection. Pediatrics. 1994; 94:815-819
9. Persaud D, Chandwani S, Rigaud M, et al. Delayed recognition of human immunodeficiency virus infection in preadolescent children. Pediatrics. 1992;90:688-691
10. Italian Register for HIV Infection in Children. Features of children perinatally infected with HIV-1 surviving longer than 5 years. Lancet. 1994;343:191-195
11. Grubman S, Gross E, Lerner-Weiss N, et al. Older children and adolescents living with perinatally acquired human immunodeficiency virus infection. Pediatrics. 1995;95:657-663
12. Davis SF, Byers RH, Lindegren ML, et al. Prevalence and incidence of vertically acquired HIV infection in the United States. JAMA. 1995;274: 952-955
13. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994;331:1173-1180
14. American Academy of Pediatrics, Committee on Pediatric AIDS. Evaluation and treatment of the HIV-exposed infant. Pediatrics. 1997;99: 909-917
15. Centers for Disease Control and Prevention. US Public Health Service recommendations for use of antiretroviral drugs during pregnancy for maternal health and reduction of perinatal transmission of perinatal human immunodeficiency virus type 1 in the United States. MMWR. 1997. In press
16. Centers for Disease Control and Prevention. Recommendations of the US Public Health Service Task Force on use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR. 1994;43(RR-11):1-20
17. Centers for Disease Control and Prevention. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected or perinatally exposed to human immunodeficiency virus. MMWR. 1995;44 (RR-4):1-11
18. Report of a Consensus Workshop. Early diagnosis of HIV infection in infants. J Acquir Immune Defic Syndr. 1992;5:1169-1178
19. McIntosh K, Pitt J, Brambilla D, et al. Blood culture in the first 6 months of life for the diagnosis of vertically transmitted human immunodeficiency virus infection. J Infect Dis. 1994;170:996-1000
20. Thea DM, Lamber G, Weedon J, et al. Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. Pediatrics. 1996;97:59-64
21. US Public Health Service. Guidelines for the use of antiretroviral agents in pediatric HIV infection. Federal Register. September 19, 1997
22. Englund JA, Baker CJ, Raskino C, et al. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. N Engl J Med. 1997;336:1704-1712
23. McKinney RE for the PACTG Protocol 300 Team. Pediatric ACTG Trial 300: Clinical efficacy of ZDV/3TC vs ddI vs ZDV/ddI in symptomatic HIV-infected children. In: Proceedings of the 35th annual meeting of the Infectious Diseases Society of America; September 13-16, 1997; San Francisco, CA: 238; Abstract 768
24. Yogev R, Stanley K, Nachman SA, et al. Virologic efficacy of ZDV + 3TC vs d4T + Ritonavir vs ZDV + 3TC + Ritonavir in stable antiretroviral-experienced children. In: Proceedings of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, Canada: 9; Abstract LB-6
25. Centers for Disease Control and Prevention. US Public Health Service recommendations for HIV counseling and testing for pregnant women. MMWR. 1995;44(No. RR-7):1-15
26. Scott DE, Hu DJ, Hanson IC, et al. Case management of HIV-infected children. Mo Public Health Rep. 1995;110:355-356
27. Phillips KA. The relationship of 1988 state HIV testing policies to previous and planned voluntary use of HIV testing. J Acquir Immune Defic Syndr. 1994;7:403-409
28. Hirano D, England B, Hoff C, et al. Reporting HIV infections. J Acquire Immune Defic Syndr. 1994;7:417-418
29. Task Force on Pediatric AIDS. Education of children with human immunodeficiency virus infection. Pediatrics. 1991;88:645-647
30. Centers for Disease Control and Prevention. Education and foster care of children infected with human T-lymphotropic virus type III/ lymphadenopathy-associated virus. MMWR. 1985;34:517-521
31. Wasser SC, Gwinn M, Fleming P. Urban-nonurban distribution of HIV infection in childbearing women in the United States. J Acquir Immune Defic Syndr. 1993;6:1035-1042
32. Fiscus SA, Adimora AA, Schoenbach VJ, et al. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties. JAMA. 1996;275:1483-1488